AbSci
  • Our Technology
  • Partnerships
  • About Us
  • Careers
  • News / Updates
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page
AbSci hopes to make E. Coli great again through engineered expression system

AbSci hopes to make E. Coli great again through engineered expression system

Feb 7, 2018 | Article, News, Press

AbSci says its genetically engineered E. coli expression platform has produced yields exceeding 20 g/L for difficult to express products and threatens the dominance of mammalian systems …

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

Feb 5, 2018 | Announcement, Press

“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”

Recent Posts

  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • AbSci Announces Recent Additions to Board of Directors
  • AbSci Announces $65 Million Financing Led by Casdin Capital
  • Alpha Cancer Technologies to License AbSci’s SoluPro Strain for the Expression of Alpha-Fetoprotein

Archives

  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • January 2020
  • July 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress